JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 46 filers reported holding JANUX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267,433 | -15.9% | 26,532 | -0.9% | 0.00% | – |
| Q2 2023 | $317,854 | +97701.2% | 26,778 | -0.3% | 0.00% | – |
| Q1 2023 | $325 | -3.8% | 26,849 | +4.5% | 0.00% | – |
| Q4 2022 | $338 | -99.9% | 25,691 | +0.4% | 0.00% | -100.0% |
| Q3 2022 | $346,000 | +18.5% | 25,580 | +7.0% | 0.00% | – |
| Q2 2022 | $292,000 | +25.3% | 23,902 | +47.4% | 0.00% | – |
| Q1 2022 | $233,000 | +6.9% | 16,216 | +46.9% | 0.00% | – |
| Q4 2021 | $218,000 | -9.2% | 11,037 | -0.7% | 0.00% | – |
| Q3 2021 | $240,000 | – | 11,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |